节点文献

2015-2021年湖北省耐多药/利福平耐药结核病患者特征及治疗效果影响因素分析

Characteristics of multidrug-resistant/rifampicin-resistant tuberculosis patients and factors associated with treatment effect in Hubei,2015-2021

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨奎周丽平张玉李涛杜昕赵雁林陈伟

【Author】 Yang Kui;Zhou Liping;Zhang Yu;Li Tao;Du Xin;Zhao Yanlin;Chen Wei;Chinese Center for Disease Control and Prevention;Hubei Provincial Center for Disease Control and Prevention;

【通讯作者】 周丽平;陈伟;

【机构】 中国疾病预防控制中心湖北省疾病预防控制中心

【摘要】 目的 了解湖北省耐多药/利福平耐药结核病患者特征及治疗效果影响因素。方法 采用描述性流行病学方法,分析湖北省登记的耐多药/利福平耐药结核病患者特征,利用非条件logistic回归模型分析耐多药/利福平耐药结核病治疗效果的影响因素。结果 2015—2021年纳入分析的3 799例耐多药/利福平耐药结核病患者,以男性(72.91%)、中青年(84.71%)和农民/民工患者(37.06%)为主。耐多药/利福平耐药结核病患者治疗成功率为61.30%。单因素和多因素logistic回归结果均表明男性、年龄≥65岁、复治、职业为农民/民工、未使用阿米卡星/卷曲霉素及治疗时间≤1年患者成功治疗比例较低,且差异均有统计学意义(P<0.05)。结论 湖北省耐多药/利福平耐药结核病疫情防控的重点人群为中青年、男性及农民/民工。为提高湖北省耐多药/利福平耐药结核病患者的治疗效果,治疗时还需对年龄65岁以上的患者、男性和农民/民工人群加大关注力度。治疗方案中使用二线注射类药物,治疗后重点关注造成治疗时长较短的原因,对提高治疗效果具有一定作用。

【Abstract】 Objective To analyze the characteristics of multidrug-resistant/rifampicin-resistant tuberculosis(TB) patients and factors assocoated with treatment effect in Hubei province. Methods Descriptive epidemiological method was used to analyze the characteristics of multidrug-resistant/rifampicin-resistant TB patients in Hubei, and unconditional logistic regression model was used to identify the factors associated with the treatment effect of multidrug-resistant/rifampicin-resistant TB. Results From 2015 to 2021, a total of 3 799 patients with multidrug-resistant/rifampicin-resistant tuberculosis were included in the analysis, in whom men, middle-aged people and farmers/migrant workers accounted for 72.91%, 84.71% and37.06% respectively. The treatment success rate in the patients was 61.30%. Both univariate and multivariate logistic regression analysis results showed that the proportion of unsuccessful treatment was higher in men, those aged ≥65 years,retreatment cases, farmers/migrant workers, those using no Amikacin/Capreomycin and those with treatment duration ≤1year, and all the difference was statistically significant(P<0.05). Conclusion Young and middle-aged people, men and famers/migrant workers are key population in the prevention and control of multidrug-resistant/rifampicin-resistant TB in Hubei. In the treatment of multidrug/rifampicin-resistant TB patients, more attention should be paid to those aged ≥65 years,men and farmers/migrant workers, the second-line injectable drugs are suggested to use and identifying the reasons causing shorter treatment duration can improve treatment outcomes.

【基金】 国家自然科学基金(No.1207011627)~~
  • 【文献出处】 疾病监测 ,Disease Surveillance , 编辑部邮箱 ,2023年05期
  • 【分类号】R52
  • 【下载频次】59
节点文献中: 

本文链接的文献网络图示:

本文的引文网络